Search
China's Drug Approval Surge: 43 Innovative Medicines Approved in H1, Nearing Last Year's Total, Covering Rare Diseases, Tumors, and More
1 week ago /
Read about 0 minute
Author：小编
In the first half of this year, China witnessed a remarkable surge in drug approvals, with 43 innovative medicines gaining the green light—a 59% increase from the same period last year. This figure is fast approaching the total of 48 approvals recorded for the entire year of 2024. These newly approved innovative drugs span various disease areas, including oncology, metabolism, and immunology. Notably, the list includes China's pioneering gene therapy product for hemophilia B and a therapeutic drug specifically targeting rare immune metabolic diseases.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
